2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy

Clinical trial NCT03468335 · COMPLETED

Trial details

NCT number: NCT03468335
Sponsor: AIO-Studien-gGmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced Pancreatic Cancer Metastatic Pancreatic Cancer

Start date: 2018-03-31
Primary completion: 2022-05-31
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.